Veera Nurmela
Doctoral Student
Institute of Biomedicine, School of Medicine, Faculty of Health Sciences
Publications
5/5 items-
Evaluation of the predictive and prognostic potential of blood immune cell profiles in metastatic cancer patients treated with immune checkpoint inhibitors
Nurmela, Veera; Schroderus, Anna Mari; Tiainen, Satu; Kuittinen, Outi; Tenhunen, Olli; Jokimäki, Anna; Suoranta, Sanna; Pasonen-Seppänen, Sanna; Sievänen, Tero; Kinnunen, Tuure; Rönkä, Aino, 2026, Cancer immunology immunotherapy, 75, 5, 161. A1 Journal article (refereed), original research -
Immune checkpoint inhibitors in the treatment of cancer : prognostic biomarkers and management of adverse events
Nurmela, Veera, 2026, Publications of the University of Eastern Finland. Dissertations in Health Sciences. G5 Doctoral dissertation (article) -
The Long-Term Sequelae and Clinical Workload Resulting from Toxicities of Immune Checkpoint Inhibitor (ICI) Therapy in Patients with Cancer
Nurmela, Veera; Juntunen, Anni; Tiainen, Satu; Martikainen, Janne; Pasonen-Seppänen, Sanna; Rönkä, Aino, 2026, Drugs - real world outcomes, [Published: 23 June 2026], 1-10. A1 Journal article (refereed), original research -
Poor survival of metastatic cancer patients hospitalized due to immune checkpoint inhibitor-related adverse events
Nurmela, Veera; Juntunen, Anni; Selander, Tuomas; Pasonen-Seppänen, Sanna; Kuittinen, Outi; Tiainen, Satu; Rönkä, Aino, 2025, Immunotherapy, 17, 5, 339-346. A1 Journal article (refereed), original research -
A practical prognostic peripheral blood-based risk model for the evaluation of the likelihood of a response and survival of metastatic cancer patients treated with immune checkpoint inhibitors
Tiainen, Satu; Nurmela, Veera; Selander, Tuomas; Turunen, Patrik; Pasonen-Seppänen, Sanna; Kettunen, Tiia; Kuittinen, Outi; Auvinen, Päivi; Rönkä, Aino, 2023, Bmc cancer, 23, 1, 1186. A1 Journal article (refereed), original research